Literature DB >> 10900392

Association between a polymorphism of ubiquitin carboxy-terminal hydrolase L1 (UCH-L1) gene and sporadic Parkinson's disease.

.   

Abstract

We found a novel polymorphism (S/Y18) of ubiquitin carboxy-terminal hydrolase L1 (UCH-L1) gene a mutation of which is expected to contribute to the etiology of a form of familial Parkinson's disease (PD). We report the frequency of this polymorphism in 313 patients with sporadic PD and 302 control subjects (Japanese and Caucasians). The frequency of the mutant allele (Y) was significantly higher in Japanese control subjects (51.2%) than in Japanese PD patients (43.4%) (chi(2)=3.917, p=0.048<0.05). It appears that this polymorphism has a weak protective factor against PD in at least the Japanese population. The frequencies of Y allele and S/Y and Y/Y genotypes in the PD patients and the controls were more significantly higher in Japanese than in Caucasian population (p<0.0001). It seems that the role of this polymorphism in PD may be different between Caucasian and Japanese populations.

Entities:  

Year:  2000        PMID: 10900392     DOI: 10.1016/s1353-8020(00)00015-8

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  13 in total

1.  The UCHL1 S18Y polymorphism and Parkinson's disease in a Japanese population.

Authors:  Katherine W Snapinn; Eric B Larson; Hideshi Kawakami; Hiroshi Ujike; Amy R Borenstein; Yuishin Izumi; Ryuji Kaji; Hirofumi Maruyama; Ignacio F Mata; Hiroyuki Morino; Masaya Oda; Debby W Tsuang; Dora Yearout; Karen L Edwards; Cyrus P Zabetian
Journal:  Parkinsonism Relat Disord       Date:  2011-02-22       Impact factor: 4.891

Review 2.  Pathological proteins in Parkinson's disease: focus on the proteasome.

Authors:  Heather Snyder; Benjamin Wolozin
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

Review 3.  Association between ubiquitin carboxy-terminal hydrolase-L1 S18Y variant and risk of Parkinson's disease: the impact of ethnicity and onset age.

Authors:  Ying Liu; Yan-Yan Chen; Hui Liu; Ci-Jiang Yao; Xiao-Xia Zhu; Dao-Jun Chen; Jin Yang; You-Jin Lu; Ji-Yu Cao
Journal:  Neurol Sci       Date:  2014-11-06       Impact factor: 3.307

Review 4.  Lack of association between UCHL1 S18Y gene polymorphism and Parkinson's disease in the Asian population: a meta-analysis.

Authors:  Shuang Sun; Yan Zhao; Guojiang Jin; Hui Kang
Journal:  Neurol Sci       Date:  2014-10-30       Impact factor: 3.307

Review 5.  The genetics of Parkinson's disease.

Authors:  Kah Leong Lim; Valina L Dawson; Ted M Dawson
Journal:  Curr Neurol Neurosci Rep       Date:  2002-09       Impact factor: 5.081

6.  USP17 regulates Ras activation and cell proliferation by blocking RCE1 activity.

Authors:  James F Burrows; Alyson A Kelvin; Cheryl McFarlane; Roberta E Burden; Michael J McGrattan; Michelle De la Vega; Ureshnie Govender; Derek J Quinn; Karim Dib; Massimo Gadina; Christopher J Scott; James A Johnston
Journal:  J Biol Chem       Date:  2009-02-02       Impact factor: 5.157

Review 7.  Parkinson's disease: Exit toxins, enter genetics.

Authors:  Marie Westerlund; Barry Hoffer; Lars Olson
Journal:  Prog Neurobiol       Date:  2009-11-17       Impact factor: 11.685

8.  Lack of evidence for an association between UCHL1 S18Y and Parkinson's disease.

Authors:  Carolyn M Hutter; Ali Samii; Stewart A Factor; John G Nutt; Donald S Higgins; Thomas D Bird; Alida Griffith; John W Roberts; Berta C Leis; Jennifer S Montimurro; Denise M Kay; Karen L Edwards; Haydeh Payami; Cyrus P Zabetian
Journal:  Eur J Neurol       Date:  2007-12-18       Impact factor: 6.089

Review 9.  Association between the ubiquitin carboxyl-terminal esterase L1 gene (UCHL1) S18Y variant and Parkinson's Disease: a HuGE review and meta-analysis.

Authors:  Margaret Ragland; Carolyn Hutter; Cyrus Zabetian; Karen Edwards
Journal:  Am J Epidemiol       Date:  2009-10-28       Impact factor: 4.897

10.  Targeting the progression of Parkinson's disease.

Authors:  J L George; S Mok; D Moses; S Wilkins; A I Bush; R A Cherny; D I Finkelstein
Journal:  Curr Neuropharmacol       Date:  2009-03       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.